HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

NIH-defined graft-versus-host disease and evidence for a potent graft-versus-leukemia effect in patients with acute lymphoblastic leukemia.

AbstractBACKGROUND:
The prognostic value of the NIH consensus criteria for graft-versus-host disease (GVHD) is not well defined yet.
PATIENTS AND METHODS:
We analyzed NIH-defined GVHD in 147 acute lymphoblastic leukemia (ALL) patients.
RESULTS:
The cumulative incidence of classic acute GVHD (aGVHD), late aGVHD and chronic GVHD (cGVHD) was 63%, 12% and 41%, respectively. cGVHD was subclassified as classic versus overlap syndrome in 40% versus 60% of cases. In multivariate Cox regression analysis with GVHD as time-dependent covariate, classic aGVHD grade III/IV had a negative impact on overall survival (OS) due to higher non-relapse mortality. cGVHD of any grade was associated with superior OS, which was due to lower relapse incidence. Classic cGVHD versus overlap syndrome had no differential impact. In 44 patients without GVHD after transplant who received donor lymphocyte infusions (DLI), the cumulative incidence of classic aGVHD, late aGVHD or cGVHD was 60%, 5% and 57%. Occurrence of cGVHD after DLI was associated with improved OS due to lower relapse incidence.
CONCLUSIONS:
The NIH consensus criteria for GVHD clearly define prognostic subgroups in patients transplanted for ALL. The improved OS in patients developing cGVHD after transplant or DLI gives clear evidence for a potent graft-versus-leukemia effect in this indication.
AuthorsT H Terwey, T M Le Duc, P G Hemmati, P le Coutre, M Nagy, P Martus, B Dörken, R Arnold
JournalAnnals of oncology : official journal of the European Society for Medical Oncology (Ann Oncol) Vol. 24 Issue 5 Pg. 1363-70 (May 2013) ISSN: 1569-8041 [Electronic] England
PMID23247660 (Publication Type: Journal Article)
Topics
  • Adolescent
  • Adult
  • Disease-Free Survival
  • Female
  • Graft vs Host Disease
  • Graft vs Leukemia Effect
  • Hematopoietic Stem Cell Transplantation
  • Humans
  • Male
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma (therapy)
  • Transplantation Conditioning
  • Transplantation, Homologous
  • Transplants
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: